216 related articles for article (PubMed ID: 19941446)
41. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
42. Cornea and ocular surface treatment.
De Miguel MP; Alio JL; Arnalich-Montiel F; Fuentes-Julian S; de Benito-Llopis L; Amparo F; Bataille L
Curr Stem Cell Res Ther; 2010 Jun; 5(2):195-204. PubMed ID: 19941445
[TBL] [Abstract][Full Text] [Related]
43. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
44. Using stem cells to produce insulin.
Soria B; Gauthier BR; Martín F; Tejedo JR; Bedoya FJ; Rojas A; Hmadcha A
Expert Opin Biol Ther; 2015; 15(10):1469-89. PubMed ID: 26156425
[TBL] [Abstract][Full Text] [Related]
45. Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice.
Kajiyama H; Hamazaki TS; Tokuhara M; Masui S; Okabayashi K; Ohnuma K; Yabe S; Yasuda K; Ishiura S; Okochi H; Asashima M
Int J Dev Biol; 2010; 54(4):699-705. PubMed ID: 19757377
[TBL] [Abstract][Full Text] [Related]
46. Differentiation of human adipose tissue-derived stem cells into aggregates of insulin-producing cells through the overexpression of pancreatic and duodenal homeobox gene-1.
Lee J; Kim SC; Kim SJ; Lee H; Jung EJ; Jung SH; Han DJ
Cell Transplant; 2013; 22(6):1053-60. PubMed ID: 23031216
[TBL] [Abstract][Full Text] [Related]
47. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.
Karnieli O; Izhar-Prato Y; Bulvik S; Efrat S
Stem Cells; 2007 Nov; 25(11):2837-44. PubMed ID: 17615265
[TBL] [Abstract][Full Text] [Related]
48. [Progress in treating diabetes mellitus with adult stem cells].
Zhang L; Teng C; An T
Sheng Wu Gong Cheng Xue Bao; 2008 Feb; 24(2):177-82. PubMed ID: 18464596
[TBL] [Abstract][Full Text] [Related]
49. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
[TBL] [Abstract][Full Text] [Related]
50. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
[TBL] [Abstract][Full Text] [Related]
51. Diabetes mellitus: a potential target for stem cell therapy.
Burns CJ; Persaud SJ; Jones PM
Curr Stem Cell Res Ther; 2006 May; 1(2):255-66. PubMed ID: 18220871
[TBL] [Abstract][Full Text] [Related]
52. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
53. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
[TBL] [Abstract][Full Text] [Related]
54. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis.
Kuhn NZ; Tuan RS
J Cell Physiol; 2010 Feb; 222(2):268-77. PubMed ID: 19847802
[TBL] [Abstract][Full Text] [Related]
55. Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
Thakkar UG; Vanikar AV; Trivedi HL
Biomed J; 2013; 36(6):304-7. PubMed ID: 24385073
[TBL] [Abstract][Full Text] [Related]
56. Three-dimensional differentiation of bone marrow-derived mesenchymal stem cells into insulin-producing cells.
Khorsandi L; Nejad-Dehbashi F; Ahangarpour A; Hashemitabar M
Tissue Cell; 2015 Feb; 47(1):66-72. PubMed ID: 25554603
[TBL] [Abstract][Full Text] [Related]
57. Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells.
Kondo Y; Toyoda T; Ito R; Funato M; Hosokawa Y; Matsui S; Sudo T; Nakamura M; Okada C; Zhuang X; Watanabe A; Ohta A; Inagaki N; Osafune K
Diabetologia; 2017 Aug; 60(8):1454-1466. PubMed ID: 28534195
[TBL] [Abstract][Full Text] [Related]
58. Cell differentiation: therapeutical challenges in diabetes.
Roche E; Vicente-Salar N; Arribas M; Paredes B
J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow mesenchymal stem cells ameliorate inflammatory factor-induced dysfunction of INS-1 cells on chip.
Sun Y; Yao Z; Lin P; Hou X; Chen L
Cell Biol Int; 2014 May; 38(5):647-54. PubMed ID: 24449503
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells.
Wu LF; Wang NN; Liu YS; Wei X
Tissue Eng Part A; 2009 Oct; 15(10):2865-73. PubMed ID: 19257811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
